This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Antitrust Europe | 14 Nov 2024

( November 14, 2024, 07:05 GMT | Press Round-Up Europe) -- Contents: - Novo Nordisk rivals get EU questions on Catalent deal - Charter Communications to take over Liberty Broadband - Biontech to buy Chinese cancer treatment specialist Biotheus - BBVA prepares remedies to secure Sabadell deal - Visa confirms EU regulator probing fees charged to retailers - Meta sued in US over Instagram, WhatsApp takeovers - EU court upholds approval of Vodafone, Liberty Global deal - European socialists object to Ribera opposition in EU ParliamentEU antitrust regulators have sent questions to Novo Nordisk’s rivals and customers asking about four business areas in the context of its planned $16.5 billion takeover of contract manufacturer Catalent. The questionnaire seeks feedback on vertical links in parts of the contract development and manufacturing organization industry, including injectables, pre-filled syringes, orally dissolved pills, and soft gels....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login